Although many of these genetic factors remain poorly understood, their effect on elastin crosslinking and airspace distention can significantly alter the natural progression of pulmonary emphysema and limit the efficacy of treatments designed to shift the balance between injury and repair. The gene discussed is ELN; the disease is pulmonary emphysema.